“jp-morgan-healthcare-conference” Archives

in
Entry Author Date Location
Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More 07/24/20 National
Verily, Santen See Ophthalmology Opportunity Via New Joint Venture 02/04/20 San Francisco
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
Mirati Stock Sale Targets $200M as Lead Cancer Drug Starts Phase 3 06/26/19 San Diego
Element Biosciences Lands $15M to Develop New Genetic Analysis Tools 06/19/19 San Diego
Halozyme Gets $30M from Argenx in Licensing Deal Worth Up to $530M 02/06/19 San Diego
Exact Looks to Sales Force, Ads to Boost Cancer Test Sales in 2018 01/08/18 Wisconsin
Allergan, Pfizer Cancel $160B Merger, Citing U.S. Treasury Actions 04/06/16 New York
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
Don’t Get Comfortable: 5 Biopharma Flashpoints to Consider in 2015 01/06/15 National
The $1K Genome? So What? Illumina Is On a Quest for World Domination 02/03/14 National
The Big Guys Have Lost Their Iron Grip, and It’s All Good 01/20/14 National
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
10 Tips for Maximizing the JP Morgan Healthcare Experience 12/23/13 National
Zillions of Biotech Conferences Want You. Which Should You Attend? 05/20/13 National
Celgene Drug Keeps Pancreatic Patients Alive an Extra Two Months in Trial 01/23/13 New York
Brook Byers of Kleiner Perkins on Sticking With Healthcare 01/16/13 San Francisco
East Coast Life Sciences Roundup: Bind, Boston Children’s, J&J, More 01/11/13 Boston
Mid-Priced Biotechnology Companies Bloom As M&A Targets in 2013 01/10/13 San Francisco
Biogen ALS Failure Highlights Clinical Trial Frustrations 01/10/13 Boston
BIND CEO Says Amgen Deal Marks Nanomedicine Turning Point 01/09/13 Boston
Biotech CEOs See Insurers as the New Boogeymen, Not FDA 01/07/13 National
My Report Card for JP Morgan Healthcare Conference Picks 01/07/13 National
Illumina Acquires Verinata Health, Prenatal Testmaker, For $350M 01/07/13 San Diego
Making a Case For Boston JP Morgan 01/02/13 Boston
CytomX Therapeutics Seeks to One-Up Lilly, Amgen Cancer Drugs 03/02/12 San Francisco
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation 01/27/12 Seattle
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Clarus Ventures Adjusts to Unpredictable Biotech World 01/20/12 Boston
Page 1 of 4 next page »